Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 26, 2011, Pages 10750-10755

  Park, Hyun Woo ^a   Kim, Joo Young ^a   Choi, Soo Kyoung ^a   Lee, Young Ho ^a   Zeng, Weizhong ^b   Kim, Kyung Hwan ^a   Muallem, Shmuel ^c   Lee, Min Goo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; PROTEIN KINASE WNK4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3;

ANIMAL CELL; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTENSION; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CELL LINE; HUMANS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRPC CATION CHANNELS; VASOCONSTRICTION;

EID: 79960605251     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1104271108     Document Type: Article

References (36)

1. Burt VL, et al. (1995) Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305-313.
2. Carretero OA, Oparil S (2000) Essential hypertension. Part I: Definition and etiology. Circulation 101:329-335.
3. Lifton RP (1996) Molecular genetics of human blood pressure variation. Science 272:676-680.
4. Wilson FH, et al. (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107-1112. (Pubitemid 32758085)
5. Lalioti MD, et al. (2006) Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38:1124-1132. (Pubitemid 44470357)
6. Yang SS, et al. (2007) Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 5:331-344.
7. He G, Wang HR, Huang SK, Huang CL (2007) Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest 117:1078-1087. (Pubitemid 46556764)
8. Kahle KT, Ring AM, Lifton RP (2008) Molecular physiology of the WNK kinases. Annu Rev Physiol 70:329-355. (Pubitemid 351738183)
9. Kahle KT, et al. (2003) WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 35:372-376. (Pubitemid 37486922)
10. Rossier BC (2003) Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension? J Clin Invest 111:947-950.
11. Kahle KT, et al. (2004) WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia. Proc Natl Acad Sci USA 101:2064-2069. (Pubitemid 38229015)
12. Inoue R, et al. (2006) Transient receptor potential channels in cardiovascular function and disease. Circ Res 99:119-131. (Pubitemid 44297035)
13. Watanabe H, Murakami M, Ohba T, Takahashi Y, Ito H (2008) TRP channel and cardiovascular disease. Pharmacol Ther 118:337-351.
14. Reading SA, Earley S, Waldron BJ, Welsh DG, Brayden JE (2005) TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries. Am J Physiol Heart Circ Physiol 288:H2055-H2061. (Pubitemid 40604087)
15. Liu D, et al. (2009) Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats. Hypertension 53:70-76.
16. Thilo F, et al. (2009) Transient receptor potential canonical type 3 channels and blood pressure in humans. J Hypertens 27:1217-1223.
17. Thilo F, Loddenkemper C, Berg E, Zidek W, TepelM (2009) Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension. Mod Pathol 22:426-430.
18. Yu Y, et al. (2004) Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci USA 101:13861-13866. (Pubitemid 39298498)
19. Hofmann T, et al. (1999) Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397:259-263.
20. Mulvany MJ, Aalkjaer C (1990) Structure and function of small arteries. Physiol Rev 70:921-961. (Pubitemid 20364819)
21. Papageorgiou P, Morgan KG (1991) Increased Ca2+ signaling after alpha-adrenoceptor activation in vascular hypertrophy. Circ Res 68:1080-1084.
22. Nishida M, Kurose H (2008) Roles of TRP channels in the development of cardiac hypertrophy. Naunyn Schmiedebergs Arch Pharmacol 378:395-406.
23. Onohara N, et al. (2006) TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 25:5305-5316. (Pubitemid 44764140)
24. Lesh RE, Somlyo AP, Owens GK, Somlyo AV (1995) Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle. Circ Res 77:220-230.
25. Wedel BJ, Vazquez G, McKay RR, St J Bird G, Putney JW, Jr. (2003) A calmodulin/ inositol 1,4,5-trisphosphate (IP3) receptor-binding region targets TRPC3 to the plasma membrane in a calmodulin/IP3 receptor-independent process. J Biol Chem 278:25758-25765. (Pubitemid 36835333)
26. Lifton RP, Gharavi AG, Geller DS (2001) Molecular mechanisms of human hypertension. Cell 104:545-556. (Pubitemid 32201949)
27. Cope G, Golbang A, O'Shaughnessy KM (2005) WNK kinases and the control of blood pressure. Pharmacol Ther 106:221-231. (Pubitemid 40603866)
28. Richardson C, Alessi DR (2008) The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. J Cell Sci 121:3293-3304.
29. Yang CL, Zhu X, Ellison DH (2007) The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 117:3403-3411. (Pubitemid 350096996)
30. Yang SS, et al. (2010) Mechanisms for hypercalciuria in pseudohypoaldosteronism type II-causing WNK4 knock-in mice. Endocrinology 151:1829-1836.
31. Woudenberg-Vrenken TE, Bindels RJ, Hoenderop JG (2009) The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol 5:441-449.
32. Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111:1039-1045. (Pubitemid 36397480)
33. Yang CL, Zhu X, Wang Z, Subramanya AR, Ellison DH (2005) Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 115:1379-1387. (Pubitemid 40629058)
34. Huang GN, et al. (2006) STIM1 carboxyl-terminus activates native SOC, I(crac) and TRPC1 channels. Nat Cell Biol 8:1003-1010.
35. Zhang H, et al. (2006) Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur J Neurosci 23:2297-2310. (Pubitemid 43742862)
36. Chamley-Campbell J, Campbell GR, Ross R (1979) The smooth muscle cell in culture. Physiol Rev 59:1-61. (Pubitemid 9106924)